Skip to main content
Year archive

NEUROTECH INTERNATIONAL LIMITED — 2020 filings

All 84 regulatory filings released by NEUROTECH INTERNATIONAL LIMITED (NTI) in 2020, sourced directly from the official regulator.

84 Filings
2020 Period
2020 filings (84)
Filing Released Lang
Results of Meeting 2 pages 131.7KB
Declaration of Voting Results & Voting Rights Announcements
2020-12-21 English
Appendix 2A 15 pages 225.1KB
Share Issue/Capital Change
2020-12-21 English
Change of Director's Interest Notice 2 pages 120.9KB
Director's Dealing
2020-12-21 English
Successful Completion of In Vitro Studies 4 pages 390.8KB
Regulatory Filings
2020-12-20 English
Update - Proposed issue of Securities - NTI 6 pages 30.5KB
Capital/Financing Update
2020-12-16 English
Update - Proposed issue of Securities - NTI 7 pages 34.3KB
Capital/Financing Update
2020-12-16 English
Change of Director's Interest Notice x 3 7 pages 460.2KB
Director's Dealing
2020-12-16 English
Disclosure Document 42 pages 462.1KB
Capital/Financing Update
2020-12-15 English
Appendix 2A 15 pages 221.5KB
Capital/Financing Update
2020-12-10 English
Further Success with Preliminary In-vitro Studies 4 pages 129.5KB
Regulatory Filings
2020-11-29 English
Reinstatement to Official Quotation 1 page 411.1KB
Regulatory Filings
2020-11-29 English
Results of Meeting 3 pages 121.5KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-29 English
Voluntary Suspension 2 pages 165.0KB
Regulatory Filings
2020-11-26 English
Trading Halt 2 pages 493.0KB
Regulatory Filings
2020-11-23 English
Notice of General Meeting/Proxy Form 20 pages 883.6KB
Proxy Solicitation & Information Statement
2020-11-22 English
Initiation of Clinical Product Formulation Studies 2 pages 76.4KB
Regulatory Filings
2020-11-18 English
Investor Presentation 15 pages 1.5MB
Investor Presentation
2020-11-15 English
Ceasing to be a substantial holder x2 4 pages 241.5KB
Major Shareholding Notification
2020-11-12 English
Quarterly Report and Appendix 4C - Additional Information 1
Interim / Quarterly Report
2020-11-11 English
Appendix 2A 15 pages 218.2KB
Regulatory Filings
2020-11-11 English
Appendix 2A 15 pages 218.2KB
Capital/Financing Update
2020-11-05 English
Disclosure Document 38 pages 403.3KB
Capital/Financing Update
2020-11-05 English
Quarterly Report and Appendix 4C 9 pages 287.1KB
Interim / Quarterly Report
2020-11-01 English
Interim Results and Capital Raising 3 pages 101.7KB
Capital/Financing Update
2020-11-01 English
Proposed issue of Securities - NTI 5 pages 28.2KB
Capital/Financing Update
2020-11-01 English
Proposed issue of Securities - NTI 6 pages 31.5KB
Capital/Financing Update
2020-11-01 English
Trading Halt 2 pages 148.6KB
Capital/Financing Update
2020-10-28 English
Notice of Annual General Meeting/Proxy Form 43 pages 1.1MB
AGM Information
2020-10-28 English
Proposed issue of Securities - NTI 7 pages 34.6KB
Capital/Financing Update
2020-10-28 English
Response to ASX Price and Volume Query 4 pages 215.1KB
Regulatory Filings
2020-10-21 English
New Chairman Appointed 2 pages 73.3KB
Board/Management Information
2020-10-18 English
Proposed issue of Securities - NTI 7 pages 33.6KB
Capital/Financing Update
2020-10-18 English
Initial and Final Director's Interest Notices 6 pages 464.3KB
Director's Dealing
2020-10-18 English
Change of Director's Interest Notice x 4 11 pages 628.0KB
Director's Dealing
2020-10-05 English
Becoming a substantial holder 2 pages 42.2KB
Major Shareholding Notification
2020-10-01 English
Completion of Acquisition 2 pages 71.6KB
Capital/Financing Update
2020-09-29 English
NTI Commences Landmark In Vitro Trials of Cannabis Strains 2 pages 79.9KB
Regulatory Filings
2020-09-22 English
Ceasing to be a substantial holder 2 pages 14.5KB
Major Shareholding Notification
2020-09-09 English
Neurotech Proceeds to in vitro trials after Positive Results 7 pages 488.5KB
Regulatory Filings
2020-09-06 English
Completion of Placement 1 page 64.2KB
Capital/Financing Update
2020-09-06 English
Neurotech secures Brain Therapeutics as Greece distributor 2 pages 85.6KB
Regulatory Filings
2020-09-02 English
Appendix 2A 15 pages 220.3KB
Regulatory Filings
2020-09-01 English
Results of Meeting 3 pages 95.9KB
Declaration of Voting Results & Voting Rights Announcements
2020-08-30 English
Appendix 4E and Annual Report 69 pages 746.9KB
Annual Report
2020-08-30 English
Appendix 4G 26 pages 403.8KB
Governance Information
2020-08-30 English
Appendix 4E and Annual Report Updated 69 pages 760.8KB
Annual Report
2020-08-30 English
Disclosure Document 44 pages 440.7KB
Capital/Financing Update
2020-08-25 English
Promising Early Results from Cannabinoid Analysis 4 pages 138.0KB
Regulatory Filings
2020-08-20 English
Pause in Trading 1 page 109.1KB
Regulatory Filings
2020-08-20 English
Response to ASX price query 4 pages 674.6KB
Regulatory Filings
2020-08-20 English
Trading Halt 2 pages 161.3KB
Regulatory Filings
2020-08-18 English
Ceasing to be a substantial holder 1 page 413.9KB
Regulatory Filings
2020-08-03 English
Quarterly Report and Appendix 4C 9 pages 393.2KB
Interim / Quarterly Report
2020-07-29 English
Notice of General Meeting/Proxy Form 37 pages 1.2MB
Proxy Solicitation & Information Statement
2020-07-27 English
Neurotech commences assays on Dolce cannabis strains 3 pages 194.3KB
Regulatory Filings
2020-07-26 English
Appendix 2A 15 pages 221.6KB
Capital/Financing Update
2020-07-21 English
Change in substantial holding 3 pages 129.6KB
Major Shareholding Notification
2020-07-14 English
Disclosure Document 38 pages 380.8KB
Capital/Financing Update
2020-07-14 English
NTI Secures Option to Cannabis Strains Targeting Autism 5 pages 145.1KB
Capital/Financing Update
2020-07-02 English
Proposed issue of Securities - NTI 10 pages 42.2KB
Capital/Financing Update
2020-07-02 English
Proposed issue of Securities - NTI 5 pages 27.6KB
Capital/Financing Update
2020-07-02 English
Trading Halt 2 pages 338.4KB
Capital/Financing Update
2020-06-30 English
Response to ASX Price and Volume Query 4 pages 250.9KB
Regulatory Filings
2020-04-30 English
Reinstatement to Official Quotation 1 page 74.3KB
Regulatory Filings
2020-04-30 English
Quarterly Report and Appendix 4C 7 pages 224.9KB
Interim / Quarterly Report
2020-04-28 English
Continued Suspension 1 page 116.0KB
Regulatory Filings
2020-04-27 English
Continued Suspension 1 page 93.8KB
Regulatory Filings
2020-04-19 English
Suspension from Official Quotation 2 pages 189.5KB
Regulatory Filings
2020-04-13 English
Mente receives CE Mark renewal for use with ASD Children 2 pages 170.2KB
Regulatory Filings
2020-04-08 English
Becoming a substantial holder x4 8 pages 6.0MB
Regulatory Filings
2020-04-08 English
Pause In Trade 1 page 110.9KB
Regulatory Filings
2020-04-07 English
Trading Halt 2 pages 219.6KB
Regulatory Filings
2020-04-07 English
Secondary Trading Notice & Appendix 2A 17 pages 337.2KB
Capital/Financing Update
2020-04-05 English
Appendix 3G 12 pages 219.2KB
Share Issue/Capital Change
2020-04-05 English
Mente Continues to Build Awareness in Europe 2 pages 134.0KB
Regulatory Filings
2020-03-25 English
Secondary Trading Notice & Appendix 2A 17 pages 292.0KB
Share Issue/Capital Change
2020-03-03 English
Appendix 3G 12 pages 219.4KB
Share Issue/Capital Change
2020-03-03 English
Appendix 4D & Half Year Report 22 pages 410.1KB
Interim / Quarterly Report
2020-02-24 English
New Mente Autism Therapy Referral Program 2 pages 134.0KB
Regulatory Filings
2020-02-23 English
Response to Appendix 4C Query 4 pages 276.4KB
Regulatory Filings
2020-02-16 English
Ceasing to be a substantial holder 2 pages 530.5KB
Regulatory Filings
2020-02-03 English
Quarterly Report and Appendix 4C 8 pages 339.6KB
Interim / Quarterly Report
2020-02-02 English
Cancellation of Mente Device from Australian TGA Register 2 pages 98.0KB
Regulatory Filings
2020-01-27 English
Trading Halt 2 pages 160.7KB
Regulatory Filings
2020-01-23 English